Overview
Brian Smith is a Hematologist Oncology specialist and a Hematologist in Rochester, New York. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Small Cell Lung Cancer (SCLC).
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
738 Library Rd, Rochester, NY 14642
601 Elmwood Ave, Box 684, Rochester, NY 14642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Rochester
Makiko Ban-Hoefen is a Hematologist Oncology specialist and a Hospital Medicine provider in Rochester, New York. Dr. Ban-Hoefen is rated as an Advanced provider by MediFind in the treatment of Primary Immunodeficiency (PID). Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Anemia, Familial Colorectal Cancer, and Multiple Myeloma.
Rpci Oncology, PC
Adam Kotowski is a Hematologist Oncology specialist and a Hematologist in Williamsville, New York. Dr. Kotowski is rated as a Distinguished provider by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Hemophilia B, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration.
University Of Rochester
Jane Liesveld is a Hematologist and an Oncologist in Rochester, New York. Dr. Liesveld is rated as an Elite provider by MediFind in the treatment of Primary Immunodeficiency (PID). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Immune ThrombocytopeniaDr. Smith isDistinguished. Learn about Adult Immune Thrombocytopenia.
- Hemangioma Thrombocytopenia SyndromeDr. Smith isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- ThrombocytopeniaDr. Smith isDistinguished. Learn about Thrombocytopenia.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Smith isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Smith isAdvanced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Smith isAdvanced. Learn about EGFR Positive Lung Cancer.
- Gastric LymphomaDr. Smith isAdvanced. Learn about Gastric Lymphoma.
- Immune Thrombocytopenic Purpura (ITP)
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Mountain SicknessDr. Smith isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Smith isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Smith isExperienced. Learn about Acute Promyelocytic Leukemia.